AVDL
Avadel Pharmaceuticals
AVDL
AVDL
65 hedge funds and large institutions have $88.5M invested in Avadel Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less call options, than puts
Call options by funds: $160K | Put options by funds: $354K
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
65
Holding in Top 10
–
Calls
$160K
Puts
$354K
Top Buyers
| 1 | +$5.99M | |
| 2 | +$1.3M | |
| 3 | +$299K | |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$225K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$129K |
Top Sellers
| 1 | -$2.06M | |
| 2 | -$2.03M | |
| 3 | -$1.66M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$924K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$830K |